Chagas Disease

• FDA approval · 2023-06-02
  FDA Approved: LAMPIT — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

  The FDA approved a supplemental application for Lampit (nifurtimox) from Bayer HealthCare Pharmaceuticals Inc., signaling an update to its l…

• FDA approval · 2023-02-22
  FDA Approved: LAMPIT — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

  FDA supplemental application for Lampit (nifurtimox) from Bayer HealthCare Pharmaceuticals Inc., seeking regulatory action on an updated ind…

• FDA approval · 2022-01-27
  FDA Approved: LAMPIT — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

  FDA approved a supplemental application for Lampit (nifurtimox) from Bayer HealthCare Pharmaceuticals Inc., expanding the drug's approved in…

• FDA approval · 2020-10-02
  FDA Approved: LAMPIT — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

  The FDA approved a supplemental application for Lampit (nifurtimox) from Bayer HealthCare Pharmaceuticals Inc., supporting its regulatory ap…

• FDA approval · 2020-08-06
  FDA Approved: LAMPIT — Original Application (Bayer HealthCare Pharmaceuticals Inc.)

  FDA approves Lampit (nifurtimox) under an original application by Bayer for the treatment of Chagas disease.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2019-11-07
  FDA Approved: BENZNIDAZOLE — Supplemental Application (Exeltis USA, Inc.)

  The FDA approved a supplemental application for benznidazole from Exeltis USA, Inc., updating the labeling for this product. This reflects a…

• FDA approval · 2017-08-29
  FDA Approved: BENZNIDAZOLE — Original Application (Exeltis USA, Inc.)

  FDA approved the original application for benznidazole (Exeltis USA, Inc.) to treat Chagas disease.